Skip to content
buyNotable cluster of 5

Aaron G.L. Fletcher bought $1.8M of CGTX

director at COGNITION THERAPEUTICS INC. 1,500,000 shares at an average of $1.20, traded Nov 15, 2022, filed Nov 16, 2022.

Conviction score
73
Value
$1.8M
1,500,000 shares
Holdings after
299,608
+1138% from before
From 52-week low
+24%
low $1.17, close $1.45
From 52-week high
-87%
high $11.52, as of Nov 15, 2022

Score components

  • Role
    Director
    +15
  • Trade size
    $1.8M at market
    +25
  • Relative to holdings
    Holdings up 1138%
    +10
  • Price context
    87% below the 52-week high
    +8
  • Cluster
    5 insiders buying within 14 days
    +15
  • Repeat buying
    First buy in 90 days
    0
  • Track record
    Too few past buys to judge (2 with prices)
    0

What happened after comparable buys

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

CGTXOct 12, 2026 · close 0.86
Since filing Nov 16, 2022: -37.4%SPY +107.2% · excess -144.7%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0001104659-22-119341, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Nov 15, 2022POpen-market purchase
Common Stockindirect: By Bios Fund III NT, LP
+184,270$1.20$221k316,038Nov 16, 2022
Nov 15, 2022POpen-market purchase
Common Stockindirect: By Bios Fund III QP, LP
+1,141,030$1.20$1.4M1,955,677Nov 16, 2022
Nov 15, 2022POpen-market purchase
Common Stockindirect: Bios Fund III, LP
+174,700$1.20$210k299,608Nov 16, 2022

Related signals

Other insiders at COGNITION THERAPEUTICS INC and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
38Weak
CGTXbuy 3
COGNITION THERAPEUTICS INC
Anthony Caggiano
Chief Medical Officer
$11k
10,000 shares
+1%
43Moderate
CGTXbuy 3
COGNITION THERAPEUTICS INC
Lisa Ricciardi
CEO & President
$10k
9,175 shares
+1%
45Moderate
CGTXbuy 3
COGNITION THERAPEUTICS INC
John Brendan Doyle
Chief Financial Officer
$11k
10,000 shares
+2%
38Weak
CGTXbuy
COGNITION THERAPEUTICS INC
Lisa Ricciardi
CEO & President
$30k
38,851 shares
-
33Weak
CGTXbuy
COGNITION THERAPEUTICS INC
Lisa Ricciardi
CEO & President
$9,975
5,700 shares
+2%
49Moderate
CGTXbuy 5
COGNITION THERAPEUTICS INC
Aaron G.L. Fletcher
director, owner
$43k
16,064 shares
+5%
49Moderate
CGTXbuy 5
COGNITION THERAPEUTICS INC
Leslie W. Kreis
director, owner
$43k
16,064 shares
+5%
51Moderate
CGTXbuy 5
COGNITION THERAPEUTICS INC
Ellen B Richstone
director
$27k
10,000 shares
-
59Moderate
CGTXbuy 5
COGNITION THERAPEUTICS INC
Aaron G.L. Fletcher
director
$99k
71,000 shares
+22%
59Moderate
CGTXbuy 5
COGNITION THERAPEUTICS INC
Leslie W. Kreis
director
$99k
71,000 shares
+22%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Aaron G.L. Fletcher bought $1.8M of CGTX | InsiderTell